{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T09:19:36Z","timestamp":1708161576627},"reference-count":0,"publisher":"SanovaWorks","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JDD"],"published-print":{"date-parts":[[2021,8,1]]},"DOI":"10.36849\/jdd.6217","type":"journal-article","created":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T18:24:36Z","timestamp":1643394276000},"page":"829-836","source":"Crossref","is-referenced-by-count":1,"title":["Fixed-Combination Halobetasol Propionate\/Tazarotene Lotion for Psoriasis in Patients With 3%\u20135% Affected Body Surface Area"],"prefix":"10.36849","volume":"20","author":[{"given":"Emil","family":"Tanghetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neal","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Drew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abby","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"22713","published-online":{"date-parts":[[2021,7,1]]},"container-title":["Journal of Drugs in Dermatology"],"original-title":[],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T18:24:58Z","timestamp":1643394298000},"score":1,"resource":{"primary":{"URL":"https:\/\/jddonline.com\/articles\/dermatology\/S1545961621P0829X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,1]]},"references-count":0,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,7,1]]},"published-print":{"date-parts":[[2021,8,1]]}},"URL":"https:\/\/doi.org\/10.36849\/jdd.6217","relation":{},"ISSN":["1545-9616"],"issn-type":[{"value":"1545-9616","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7,1]]}}}